DIVISLABNSEDivi's Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 25 May · 14:20 IST

Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.3%1-day move
₹6900.00
prior close
₹6784.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1-0.1-0.3-0.4-2.3-1.6-3.2-5.0-5.7-4.6-2.5-2.9+7.8
Up moveDown movePending
AI summary

Divi's Laboratories has submitted newspaper clippings of its audited standalone and consolidated financial results for Q4 and full year ended March 31, 2026. The board of directors approved these results at their meeting on May 23, 2026. The results were published on May 24, 2026 in Financial Express (English) and Andhra Prabha (Telugu) newspapers as per SEBI regulations. The actual financial numbers are not included in this filing notice — they would be available on the company's website.

Likely market impact

This is a routine regulatory filing confirming publication of quarterly and annual results. The actual financial performance numbers will need to be reviewed separately to assess impact on the stock. Investors should check the full results published on the company website for revenue, profit, and other key metrics.